Financial Snapshot

Revenue
$38.21K
TTM
Gross Margin
50.0%
TTM
Net Earnings
$407.9K
TTM
Current Assets
Q1 2024
Current Liabilities
Q1 2024
Current Ratio
0.87%
Q1 2024
Total Assets
Q1 2024
Total Liabilities
Q1 2024
Book Value
-$1.441M
Q1 2024
Cash
Q1 2024
P/E
52.77
Sep 18, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Revenue $60.45K $11.13K $5.550K $24.58K $646.6K $294.9K $272.2K $0.00 $125.0K $13.00K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 443.01% 100.59% -77.42% -96.2% 8.36% -100.0% 861.54%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Revenue $60.45K $11.13K $5.550K $24.58K $646.6K $294.9K $272.2K $0.00 $125.0K $13.00K $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $85.61K $7.507K $262.6K $22.54K $902.2K $169.4K $167.6K
Gross Profit -$25.16K $3.626K -$257.1K $2.040K -$255.6K $125.5K $104.6K
Gross Profit Margin -41.61% 32.57% -4631.89% 8.3% -39.52% 42.56% 38.42%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Selling, General & Admin $1.166M $795.0K $2.058M $6.123M $1.629M $278.0K $380.9K $761.0K $492.0K $576.0K $1.170M $5.230M $140.0K $0.00 $0.00
YoY Change 46.67% -61.37% -66.39% 275.94% -27.01% 54.67% -14.58% -50.77% -77.63% 3635.71%
% of Gross Profit 21924.71% 300170.59% 221.46% 364.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $82.47K $82.08K $167.5K $120.3K $93.92K $1.000K $0.00 $13.00K $10.00K $0.00
YoY Change 0.48% -51.01% 39.28% 28.08% -100.0% 30.0%
% of Gross Profit 2263.54% 5896.57%
Operating Expenses $1.166M $795.0K $2.225M $6.244M $1.723M $278.0K $380.9K $761.0K $492.0K $576.0K $1.170M $5.230M $140.0K $0.00 $0.00
YoY Change 46.67% -64.28% -64.36% 262.43% -27.01% 54.67% -14.58% -50.77% -77.63% 3635.71%
Operating Profit -$1.191M $791.4K -$2.482M -$6.242M -$1.978M -$152.5K -$276.3K
YoY Change -250.52% -131.88% -60.23% 215.5% -44.82%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Interest Expense -$55.18K -$32.51K -$33.04K -$31.18K -$38.04K -$62.57K -$61.54K -$5.319M -$586.0K -$801.0K -$1.410M $0.00
YoY Change 69.73% -1.6% 5.97% -18.03% 1.67% 807.68% -26.84% -43.19%
% of Operating Profit -4.11%
Other Income/Expense, Net -$3.550K $0.00 $105.7K $0.00 -$25.00K -$10.46M -$6.106M -$200.0K $0.00
YoY Change -100.0% -100.0% 71.37% 2953.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Pretax Income -$1.332M -$905.9K -$2.796M -$6.273M -$2.041M -$215.0K -$337.8K -$16.80M -$7.306M -$1.706M -$2.580M -$5.230M -$140.0K $0.00 $0.00
YoY Change 47.07% -67.6% -55.43% 207.29% -36.35% 129.99% 328.25% -33.88% -50.67% 3635.71%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings $1.332M $905.9K -$2.796M -$6.273M -$2.041M -$215.0K -$337.8K -$16.80M -$7.306M -$1.706M -$2.580M -$5.230M -$140.0K $0.00 $0.00
YoY Change 47.07% -132.4% -55.43% 207.29% -36.35% 129.99% 328.25% -33.88% -50.67% 3635.71%
Net Earnings / Revenue 2203.95% 8137.47% -50374.23% -25520.38% -315.7% -72.91% -124.13% -5844.8% -13123.08%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$1.065K -$28.96K -$51.92K -$41.38K -$231.1K -$19.15M -$25.48M -$13.91M -$3.471B -$10.86B -$2.101B $0.00 -$1.310M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Cash & Short-Term Investments $79.35K $2.850K $197.3K $247.9K $91.58K $340.00 $60.00 $1.000K $0.00 $250.0K $40.00K $0.00 $0.00 $0.00 $0.00
YoY Change 2684.21% -98.56% -20.42% 170.68% 466.67% -100.0% 525.0%
Cash & Equivalents $79.35K $2.850K $197.3K $247.9K $91.58K $340.00 $60.00 $1.000K
Short-Term Investments
Other Short-Term Assets $38.00K $2.000K $0.00 $10.00K $30.00K $0.00
YoY Change -100.0% -66.67%
Inventory $0.00 $231.0K $231.0K
Prepaid Expenses
Receivables $0.00 $750.00 $900.00 $180.00 $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $79.35K $3.600K $198.2K $479.0K $360.5K $340.00 $60.00 $3.000K $0.00 $270.0K $70.00K $0.00 $0.00 $0.00 $0.00
YoY Change 2104.17% -98.18% -58.63% 32.87% 466.67% -100.0% 285.71%
Property, Plant & Equipment $1.075M $1.158M $1.240M $1.645M $646.2K $2.000K $0.00 $0.00 $30.00K $0.00
YoY Change -7.12% -6.62% -24.65% 154.61% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $125.0K $2.899M $1.580M $5.720M $380.0K $560.0K $0.00
YoY Change 83.48% -72.38% 1405.26% -32.14%
Other Assets $530.00 $530.00 $530.00 $530.00 $4.530K $0.00 $50.00K $0.00
YoY Change 0.0% 0.0% 0.0% -88.3% -100.0%
Total Long-Term Assets $1.201M $1.158M $1.240M $1.646M $650.8K $0.00 $0.00 $2.901M $1.580M $5.720M $450.0K $560.0K $6.040M $0.00 $0.00
YoY Change 3.67% -6.62% -24.64% 152.92% 83.61% -72.38% 1171.11% -19.64% -90.73%
Total Assets $1.280M $1.162M $1.438M $2.125M $1.011M $340.00 $60.00 $2.904M $1.580M $5.990M $520.0K $560.0K $6.040M $0.00 $0.00
YoY Change
Accounts Payable $140.8K $98.72K $154.8K $637.1K $156.9K $398.2K $323.2K $85.00K $100.0K $30.00K $120.0K $110.0K $130.0K
YoY Change 42.6% -36.21% -75.71% 306.13% 23.21% -15.0% 233.33% -75.0% 9.09% -15.38%
Accrued Expenses $1.341M $1.051M $754.1K $91.62K $103.0K $296.1K $233.5K $1.529M $50.00K $130.0K $60.00K
YoY Change 27.56% 39.36% 723.06% -11.07% 26.8% 2958.0% -61.54% 116.67%
Deferred Revenue
YoY Change
Short-Term Debt $952.8K $591.6K $340.9K $340.9K $200.0K $391.5K $391.5K $4.413M $1.340M $0.00 $0.00 $30.00K $30.00K $0.00 $0.00
YoY Change 61.05% 73.56% 0.0% 70.43% 0.0% 229.33% -100.0% 0.0%
Long-Term Debt Due $25.04K
YoY Change
Total Short-Term Liabilities $2.505M $1.789M $1.302M $1.115M $459.9K $1.163M $948.2K $6.077M $1.490M $160.0K $120.0K $130.0K $380.0K $0.00
YoY Change 40.03% 37.43% 16.74% 142.49% 22.71% 307.85% 831.25% 33.33% -7.69% -65.79%
Long-Term Debt $78.72K $125.6K $148.6K $314.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00 $0.00 $0.00 $0.00
YoY Change -37.34% -15.43% -52.69% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $78.72K $125.6K $148.6K $314.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00 $0.00 $0.00 $0.00
YoY Change -37.34% -15.43% -52.69% -100.0%
Total Liabilities $2.584M $1.915M $1.450M $1.429M $459.9K $1.163M $948.2K $6.077M $1.490M $160.0K $130.0K $130.0K $380.0K $0.00
YoY Change 34.95% 32.01% 1.49% 210.77% 22.71% 307.85% 831.25% 23.08% 0.0% -65.79%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000
Basic Shares Outstanding 2.691B shares 2.681B shares 2.624B shares
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $21.525 Million

About Real Brands Inc

Real Brands, Inc. engages in the provision of a hemp-derived cannabinol (CBD) market. The company is headquartered in Pompano Beach, Florida and currently employs 1 full-time employees. The company went IPO on 2005-10-10. The Company’s primary business is hemp cannabinoids (CBD) oil/isolate extraction, wholesaling of CBD oils and isolate, and manufacturing, production and sales of hemp-derived CBD consumer brands and white label products. The company is extracting and refining oils and compounds of interest from hemp cultivars using its processing technology and methodology. Its products consist of oils, tinctures, capsules, topicals, edibles, and pet products. The firm acquires and/or develops brands that CBD and minor cannabinoids are complementary ingredients, and which are conducive to hemp derived infusion or micro encapsulation that is chocolates, cosmetics, edibles, drinks, sprays, tinctures, sub-lingual strips, cooking condiments, powders, vapes, and others. The Company’s HALO.5 simulated moving bed chromatography system (SMB) is an integrated six-column SMB system designed for isolation and purification of chemical compounds.

Industry: Beverages Peers: Talphera Inc Elicio Therapeutics Inc Cocrystal Pharma Inc Clever Leaves Holdings Inc. Elite Pharmaceuticals Inc Processa Pharmaceuticals Inc Johnson & Johnson Landos Biopharma, Inc. NutriBand Inc.